作者：
Chiara,Pighi [1]
;
Taek-Chin,Cheong [2]
;
Mara,Compagno [1]
;
Enrico,Patrucco [1]
;
Maddalena,Arigoni [2]
;
Martina,Olivero [2]
;
Qi,Wang [2]
;
Cristina,López [2]
;
Stephan H,Bernhart [3]
;
Bruno M,Grande [1]
;
Teresa,Poggio [4]
;
Fernanda,Langellotto [5]
;
Lisa,Bonello [2]
;
Riccardo,Dall'Olio [1]
;
Sandra,Martínez-Martín [2]
;
Luca,Molinaro [2]
;
Paola,Francia di Celle [6]
;
Jonathan R,Whitfield [7]
;
Laura,Soucek [7]
;
Claudia,Voena [6]
;
Raffaele A,Calogero [6]
;
Ryan D,Morin [8]
;
Louis M,Staudt [9]
;
Reiner,Siebert [2]
;
Alberto,Zamò [2]
;
Roberto,Chiarle [10]
作者单位：
Department of Pathology, Boston Children's Hospital, Harvard Medical School, Boston, MA.
[1]
Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy.
[2]
Candiolo Cancer Institute , FPO-IRCCS, Candiolo (To), Italy.
[3]
Institute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm, Germany.
[4]
Computational Oncology, Sage Bionetworks, Seattle, WA.
[5]
Vall d'Hebron Institute of Oncology, Edifici Cellex, Hospital Vall d'Hebron, Barcelona, Spain.
[6]
Azienda Ospedaliera Citta' della Salute, Torino, Italy.
[7]
Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain.
[8]
Department of Biochemistry and Molecular Biology, Universitat Autònoma De Barcelona, Bellaterra, Spain.
[9]
Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada.
[10]
Lymphoid Malignancies Branch, Center for Cancer Research and Biometric Research Program, Division of Cancer Diagnosis and Treatment, National Cancer Institute, National Institutes of Health, Rockville, MD; and.
[11]
Institute of Pathology, University of Würzburg, Würzburg, Germany.
[12]
DOI
10.1182/bloodadvances.2021005682
PMID
34625792
发布时间
2022-07-16
换一批
换一批
